Stephanie Ehnert
Overview
Explore the profile of Stephanie Ehnert including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
51
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Edwards C, Karunakaran K, Garcia E, Beutler N, Gagne M, Golden N, et al.
PLoS Pathog
. 2025 Jan;
21(1):e1012456.
PMID: 39847599
The continued evolution of SARS-CoV-2 variants capable of subverting vaccine and infection-induced immunity suggests the advantage of a broadly protective vaccine against betacoronaviruses (β-CoVs). Recent studies have isolated monoclonal antibodies...
2.
Farinre O, Anaya T, King A, Endrias K, Hebert A, Hill A, et al.
PLoS Pathog
. 2025 Jan;
21(1):e1012863.
PMID: 39792949
The latent viral reservoir remains the major barrier to HIV cure, placing the burden of strict adherence to antiretroviral therapy (ART) on people living with HIV to prevent recrudescence of...
3.
Edwards C, Karunakaran K, Garcia E, Beutler N, Gagne M, Golden N, et al.
bioRxiv
. 2024 Aug;
PMID: 39109178
The continued evolution of SARS-CoV-2 variants capable of subverting vaccine and infection-induced immunity suggests the advantage of a broadly protective vaccine against betacoronaviruses (β-CoVs). Recent studies have isolated monoclonal antibodies...
4.
Pino M, Pagliuzza A, Pampena M, Deleage C, Viox E, Nguyen K, et al.
Nat Commun
. 2022 Aug;
13(1):5055.
PMID: 36030289
Antiretroviral therapy (ART) is not curative due to the persistence of a reservoir of HIV-infected cells, particularly in tissues such as lymph nodes, with the potential to cause viral rebound...
5.
Bricker K, Obregon-Perko V, Williams B, Oliver D, Uddin F, Neja M, et al.
J Virol
. 2022 Mar;
96(7):e0169921.
PMID: 35293766
The "shock and kill" strategy for HIV-1 cure incorporates latency-reversing agents (LRA) in combination with interventions that aid the host immune system in clearing virally reactivated cells. LRAs have not...
6.
Obregon-Perko V, Bricker K, Mensah G, Uddin F, Rotolo L, Vanover D, et al.
JCI Insight
. 2021 Oct;
6(23).
PMID: 34699383
Understanding viral rebound in pediatric HIV-1 infection may inform the development of alternatives to lifelong antiretroviral therapy (ART) to achieve viral remission. We thus investigated viral rebound after analytical treatment...
7.
Chahroudi A, Cartwright E, Lee S, Mavigner M, Carnathan D, Lawson B, et al.
PLoS Pathog
. 2014 Mar;
10(3):e1003958.
PMID: 24604066
Mother-to-infant transmission (MTIT) of HIV is a serious global health concern, with over 300,000 children newly infected in 2011. SIV infection of rhesus macaques (RMs) results in similar rates of...